{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:34:20Z","timestamp":1786426460219,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008323","name":"Cumberland Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008323","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Norton Children's Hospital Foundation"},{"name":"Community Fundraising by Family of Evan Riggle"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Dev Behav Pediatr"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by social communication differences and restricted interests. One proposed biologic mechanism underlying ASD is oxidative stress, leading to the clinical use of glutathione based on anecdotal reports of improved behavior in autistic children. In this pilot study, we tested this observation using a randomized clinical trial format to collect preliminary data on glutathione safety and efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Glutathione and glutathione in combination with vitamin C and N-acetylcysteine (Trio) were tested. Both treatments were administered in double-blind placebo-controlled randomized crossover studies. In total, 24 children between the ages of 5 and 16 years with ASD and severe behavior disorders were randomized to receive weekly intravenous injections of either placebo or 1 of the 2 interventions (glutathione or Trio) for 8 weeks. After a 1-week washout period, participants were crossed over for the subsequent 8 weeks. Behavioral measures and plasma levels of glutathione were obtained at baseline, during the washout period, and at the end of the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>No differences between treatment groups in behavioral or biologic measures were found. No significant adverse side effects attributable to the treatments were observed. Small improvements in specific glutathione and behavioral measures occurred over the study period for all groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Treatment with glutathione or glutathione in combination with vitamin C and N-acetylcysteine did not result in improvements in behavior or biologic measures. The positive trends over the course of the study were likely due to the placebo effect or decreased anxiety associated with the study routine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dbp.0000000000001334","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T16:00:25Z","timestamp":1737129625000},"page":"e17-e24","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Glutathione, Vitamin C, and Cysteine Use in Autistic Children With Disruptive Behavior: A Double-Blind, Placebo-Controlled Crossover Pilot Study"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-6314","authenticated-orcid":false,"given":"Patricia Gail","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Norton Children's Medical Group, School of Medicine, University of Louisville, Louisville, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie","family":"Sears","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Norton Children's Medical Group, School of Medicine, University of Louisville, Louisville, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Watson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, School of Medicine, University of Louisville, Louisville, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakeerathan","family":"Gunaratnam","sequence":"additional","affiliation":[{"name":"Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Feygin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Norton Children's Research Institute, School of Medicine, University of Louisville, Louisville, KY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Norton Children's Hospital, School of Medicine, University of Louisville, Louisville, KY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice E.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Norton Children's Research Institute, School of Medicine, University of Louisville, Louisville, KY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"R1-20250313","first-page":"1","article-title":"Prevalence of autism spectrum disorders\u2014autism and developmental disabilities monitoring network, United States, 2018","volume":"70","year":"2021","journal-title":"Surveill Summ"},{"key":"R2-20250313","first-page":"1","article-title":"Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012","volume":"65","author":"Blumberg","year":"2013","journal-title":"Natl Health Stat Reports"},{"key":"R3-20250313","first-page":"cer-01-17","article-title":"Examining the causes of autism","volume":"2017","author":"Amaral","year":"2017","journal-title":"Cerebrum"},{"key":"R4-20250313","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"R5-20250313","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"R6-20250313","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10937400600882079","article-title":"Evidence of toxicity, oxidative stress, and neuronal insult in autism","volume":"9","author":"Kern","year":"2006","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"R7-20250313","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","article-title":"Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple","volume":"30","author":"Schafer","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"R8-20250313","first-page":"986519","article-title":"Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism","volume":"2012","author":"Rose","year":"2012","journal-title":"Autism Res Treat"},{"key":"R9-20250313","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"Schulz","year":"2000","journal-title":"Eur J Biochem"},{"key":"R10-20250313","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"R11-20250313","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/bbrc.2001.5868","article-title":"An association between idiopathic Parkinson's Disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2","volume":"288","author":"Harada","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-20250313","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R13-20250313","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.clinbiochem.2009.03.011","article-title":"Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children","volume":"42","author":"Al-Gadani","year":"2009","journal-title":"Clin Biochem"},{"key":"R20-20250313","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl Psychiatry"},{"key":"R14-20250313","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R15-20250313","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2377-11-139","article-title":"Novel metabolic biomarkers related to sulfur dependent detoxification pathways in autistic patients of Saudi Arabia","volume":"11","author":"Al-Yafee","year":"2011","journal-title":"BMC Neurol"},{"key":"R16-20250313","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/acm.2009.0177","article-title":"Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures of children with autism","volume":"16","author":"Bertoglio","year":"2010","journal-title":"J Altern Complement Med"},{"key":"R17-20250313","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","article-title":"Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism","volume":"89","author":"James","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R18-20250313","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1743-7075-8-34","article-title":"Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity","volume":"8","author":"Adams","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"R19-20250313","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2008.09.005","article-title":"Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15","volume":"205","author":"Vojdani","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R21-20250313","doi-asserted-by":"crossref","first-page":"CR677","DOI":"10.12659\/MSM.882125","article-title":"A clinical trial of glutathione supplementation in autism spectrum disorders","volume":"17","author":"Kern","year":"2011","journal-title":"Med Sci Monitor"},{"key":"R23-20250313","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"R27-20250313","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0955-2863(99)00033-9","article-title":"A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection","volume":"10","author":"Melnyk","year":"1999","journal-title":"J Nutr Biochem"},{"key":"R28-20250313","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1038\/tp.2013.51","article-title":"Redox metabolism abnormalities in autistic children associated with mitochondrial disease","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry"},{"key":"R29-20250313","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-011-1260-7","article-title":"Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism","volume":"42","author":"Melnyk","year":"2012","journal-title":"J Autism Dev Disord"},{"key":"R32-20250313","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2015.01.006","article-title":"Biomarkers of oxidative stress study VI. Endogenous plasma antioxidants fail as useful biomarkers of endotoxin-induced oxidative stress","volume":"81","author":"Kadiiska","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"R30-20250313","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/cap.2015.0159","article-title":"Randomized, placebo-controlled trial of methyl B12 for children with autism","volume":"26","author":"Hendren","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R31-20250313","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/bmm.13.158","article-title":"Metabolic pathology of autism in relation to redox metabolism","volume":"8","author":"Frye","year":"2014","journal-title":"Biomark Med"},{"key":"R33-20250313","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0891-5849(00)00198-2","article-title":"Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl (4) poisoning?","volume":"28","author":"Kadiiska","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"R34-20250313","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fncel.2018.00503","article-title":"Comparison of three clinical trial treatments for autism spectrum disorder through multivariate analysis of changes in metabolic profiles and adaptive behavior","volume":"12","author":"Vargason","year":"2018","journal-title":"Front Cell Neurosci"}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:02:06Z","timestamp":1741881726000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0000000000001334","relation":{},"ISSN":["1536-7312"],"issn-type":[{"value":"1536-7312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2022-12-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}